David Hudesman, MD, on Efficacy of Tofacitinib Induction for Ulcerative Colitis

Dr Hudesman reviews the findings of a post hoc analysis to assess associations between C-reactive protein, partial Mayo score, and efficacy outcomes during tofacitinib induction that he and his colleagues conducted.